BCKDK and neoplasm: BCKDK‐overexpressing and RNF8‐silenced MDA‐468 tumors expressing RNF8WT or RNF8S157D, but not RNF8S157A, could restore tumor volume and mass, under Olaparib treatment (Figure 4j,k).